Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 53808-0338 by State Of Florida Doh Central Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

This is the label for Spironolactone Tablets 100 mg - Spironolactone 100mg(Qualitest)

This is the label for Spironolactone Tablets 100 mg - Spironolactone 100mg(Qualitest)

This is the label for Spironolactone Tablets 25 mg - Spironolactone 25mg (Qualitest)

This is the label for Spironolactone Tablets 25 mg - Spironolactone 25mg (Qualitest)

This is an image of the structural formula for spironolactone. - spironolactonetabs 1

This is an image of the structural formula for spironolactone. - spironolactonetabs 1

This text appears to be describing the molecular formula and molecular weight of a chemical compound. The compound has the molecular formula of C,H,O,S and a molecular weight of 416.57. However, no information about the name or properties of the compound is provided.*

This is Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactonetabs 2

This is Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactonetabs 2

This text seems to indicate results from a statistical analysis involving probability. Specifically, it mentions a "Log-rank p" value of less than 0.001, which likely indicates a statistically significant difference between groups being compared. Additionally, there is a timeline spanning 6 to 48 months. However, without more context or information, it is difficult to determine the exact nature of the analysis or its implications.*

This is an image of Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactonetabs 3

This is an image of Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactonetabs 3

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.